JPRN-UMIN000004572已完成未知
Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer - Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer
Tokyo Women's Medical University0 个研究点目标入组 9 人开始时间: 2010年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy Uncontrolled infection Patients with serious concomitant disease
研究者
相似试验
已完成
1 期
PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancerAdvanced or recurrent gastric cancer refractory to standard therapeutic modalityJPRN-UMIN000004389Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka University30
已完成
1 期
Phase I clinical study of peptide vaccine using novel tumor-associated antigen TTK against advanced esophageal carcinomaAdvanced esophageal cancer refractory to standard therapeutic modalityJPRN-UMIN000001014niversity of Tokyo6
已完成
1 期
Clinical trial of AFP-derived peptide vaccine for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000003514Department of Gastroenterology, Kanazawa University Hospital20
已完成
1 期
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent pancreatic cancer to be refractory to chemotherapy by using new tumor antigen KIF20A and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiopancreatic cancerJPRN-UMIN000002022Department of Gastroenterology, Juntendo University School of Medicine36
已完成
1 期
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent gastric cancer to be refractory to chemotherapy by using new tumor antigen URLC10 and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiogastric cancerJPRN-UMIN000002409Department of Gastroenterology, Juntendo University School of Medicine36